⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BIIB News
Biogen Inc. Common Stock
Investigation Alert: Biogen Inc. (BIIB) Under Scrutiny - Contact Levi & Korsinsky for Details Ready to Announce with Confidence?
newsfilecorp.com
BIIB
Eisai projects Leqembi® revenue to total JPY 143.5 billion for fiscal year 2026 (April 2026 - March 2027) USA - English USA - English
prnewswire.com
BIIB
Eisai projects Leqembi® revenue to total JPY 143.5 billion for fiscal year 2026 (April 2026 - March 2027)
prnewswire.com
BIIB
The ADDF Highlights Encouraging Progress Toward Targeting Multiple Alzheimer's Pathologies in Biogen's Phase 2 Tau Study
prnewswire.com
BIIB
Oligonucleotides Clinical Trial Drug Development Pipeline Expands with Contributions from 200+ Key Companies | DelveInsight
globenewswire.com
IONS
ALNY
NVS
BIIB
ARWR
SLN
WVE
VNDA
NSP
TCRT
AMX
CDIO
SRPT
VIR
BNTX
ARCT
GSK
PFE
McKinney Canada Adds Executive Director and Strategy Director
prnewswire.com
SCL
BMO
BIIB
Form 8-K
sec.gov
APLS
BIIB
Biogen Completes Acquisition of Apellis Pharmaceuticals
globenewswire.com
BIIB
APLS
Form 8-K
sec.gov
BIIB
Ionis partner Biogen announces topline results from Phase 2 CELIA study of diranersen (BIIB080): first study to show reduction in tau pathology and cognitive benefit in patients with early Alzheimer’s disease
businesswire.com
IONS
BIIB